Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...
Initial tranche assists CannEpil® development and commercialization Financing comes as FDA and Congress increase focus on ...
The biotech industry is in the midst of an artificial intelligence (AI) investment surge, with companies pouring billions into the promise of faster, smarter drug discovery. As leaders in R&D, we have ...
Oncology innovation is accelerating across therapeutic modalities, precision medicine, biomarkers and artificial intelligence ...
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) The following represents ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Cryptopolitan on MSN
Novo Nordisk and Anthropic collaborate to advance drug development with Claude
Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them to market. The pharmaceutical giant said Wednesday that the partnership ...
5d
What Are the Advantages of an Integrated Drug Development Model Over Multiple Specialized Vendors?
SAN DIEGO, CA, UNITED STATES, September 21, 2026 /EINPresswire.com/ -- Key Takeaways Integrated drug development can ...
The lack of new drugs is a major gap in the global fight against TB. Harrington observed that there has been a long period of stagnation in TB drug development: As noted in Chapter 1, the last new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results